| 邝敏亨刘福建关航陆兆炯姜志勇.内镜下硬化剂和套扎治疗食管静脉曲张术后对门脉高压性胃病
和胃底静脉曲张的影响[J].现代生物医学进展英文版,2014,14(20):3863-3865. |
| 内镜下硬化剂和套扎治疗食管静脉曲张术后对门脉高压性胃病
和胃底静脉曲张的影响 |
| The Impact on Portal Hypertensive Gastropathy and GastroesophagealVarices about Endoscopic Sclerotherapy and Ligationin the Treatment of Esophageal Varices |
| |
| DOI： |
| 中文关键词: 并发症 门脉高压 静脉曲张 内镜下套扎术 硬化剂 |
| 英文关键词: Complications Portal hypertension Varicose veins Endoscopic ligation Sclerotherapy |
| 基金项目: |
|
| Hits: 878 |
| Download times: 853 |
| 中文摘要: |
| 摘要目的：探讨食管静脉曲张（EV）采用内镜下套扎术(EVL)和硬化剂(EVS)治疗对患者近远期并发胃底静脉曲张（GV）以及门脉
高压性胃病（PHG）并发症的影响。方法：抽选我院肝硬化上消化道出血后接受内镜下治疗的患者97 例为研究对象，其中19 例予
以内镜下EVS 治疗，78 例行内镜下EVL治疗，随访1年，观察治疗3 个月、6 个月、1 年后并发GV、PHG的近远期概率。结果：治
疗3 个月后，本组患者GV、PHG 等并发症的发生率为17.5%（17/97）、39.2%（38/97），与治疗前比较差异无显著性（P>0.05）；治疗
6个月后，本组患者GV、PHG等并发症的发生率为32%（31/97）、70.1%（68/97），与治疗前相比，并发人数显著增加（P<0.05）；治疗
1年后，GV、PHG 的发生率为42.3%（41/97）、88.7%（86/97），并发人数显著高于治疗前（P<0.05）。结论：内镜下EVS、EVL治疗在
消退食管曲张静脉和良好地控制出血的同时，还可增加PHG、GV的并发几率，值得临床重视预防。 |
| 英文摘要: |
| ABSTRACT Objective:To explore the impact of portal hypertensive gastropathy and gastroesophageal varices about endoscopic
sclerotherapy and ligation in the treatment of esophageal varices. Methods:97 patients with bleeding after endoscopic treatment with
liver cirrhosis upper gastrointestinal were chosen, among whom 19 cases were undergone endoscopic EVS treatment, 78 cases were
undergone endoscopic treatment of EVL, 1 years of follow-up. 3 months, 6 months and 1 year later, the probability of occurring in
patients with GV and PHG was observed. Results:After 3 months of treatment, the incidence of complications such as GV and PHG was
17.5%(17/97) and 39.2%(38/97) respectively, compared with those before treatment, there was no significant difference (P>0.05); After
6 months of treatment, the incidence of complications was 32%(31/97) and 70.1% (68/97), compared with before treatment, there was a
significant increase in the number (P<0.05); After 1 year of treatment, GV, PHG rate was 42.3%(41/97) and 88.7%(86/97) respectively,
concurrent number was significantly higher than that of before treatment (P<0.05).Conclusion: Endoscopic EVS, EVL treatment can not
only control esophageal varices bleeding, but also can increase the probability of concurrent PHG, GV, is worth the clinical prevention. |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
